Apoptosis of HeLa cells inhibited by human papillomavirus type 16 E6 protein interacting with hDaxx

2008 ◽  
Vol 7 (12) ◽  
pp. 728-731
Author(s):  
Aitao He ◽  
Xin Wang ◽  
Cuiming Zhu ◽  
Hengling Cai ◽  
Yanping Wan
2005 ◽  
Vol 79 (7) ◽  
pp. 4229-4237 ◽  
Author(s):  
Arnaud Favre-Bonvin ◽  
Caroline Reynaud ◽  
Carole Kretz-Remy ◽  
Pierre Jalinot

ABSTRACT Several viral proteins expressed by DNA or RNA transforming viruses have the particular property of binding via their C-terminal end to various cellular proteins with PDZ domains. This study is focused on the PDZ protein TIP-2/GIPC, which was originally identified in two-hybrid screens performed with two different baits: the human T-cell leukemia virus type 1 Tax oncoprotein and the regulator of G signaling RGS-GAIP. Further studies have shown that TIP-2/GIPC is also able to associate with the cytoplasmic domains of various transmembrane proteins. In this report we show that TIP-2/GIPC interacts with the E6 protein of human papillomavirus type 18 (HPV-18). This event triggers polyubiquitination and proteasome-mediated degradation of the cellular protein. In agreement with this observation, silencing of E6 by RNA interference in HeLa cells causes an increase in the intracellular TIP-2/GIPC level. This PDZ protein has been previously found to be involved in transforming growth factor β (TGF-β) signaling by favoring expression of the TGF-β type III receptor at the cell membrane. In line with this activity of TIP-2/GIPC, we observed that depletion of this protein in HeLa cells hampers induction of the Id3 gene by TGF-β treatment and also diminishes the antiproliferative effect of this cytokine. Conversely, silencing of E6 increases the expression of Id3 and blocks proliferation of HeLa cells. These results support the notion that HPV-18 E6 renders cells less sensitive to the cytostatic effect of TGF-β by lowering the intracellular amount of TIP-2/GIPC.


2012 ◽  
Vol 324 (1) ◽  
pp. 109-117 ◽  
Author(s):  
Jae Eun Jong ◽  
Kwi Wan Jeong ◽  
Hyokyung Shin ◽  
Lee Rang Hwang ◽  
Daeyoup Lee ◽  
...  

Oncogene ◽  
2002 ◽  
Vol 21 (37) ◽  
pp. 5665-5672 ◽  
Author(s):  
Ilaria Malanchi ◽  
Sandra Caldeira ◽  
Maja Krützfeldt ◽  
Marianna Giarre ◽  
Marianna Alunni-Fabbroni ◽  
...  

1996 ◽  
Vol 77 (3) ◽  
pp. 459-463 ◽  
Author(s):  
N. Akutsu ◽  
H. Shirasawa ◽  
T. Asano ◽  
K. Isono ◽  
B. Simizu

2007 ◽  
Vol 82 (1) ◽  
pp. 71-76 ◽  
Author(s):  
Pedja Sekaric ◽  
Jonathan J. Cherry ◽  
Elliot J. Androphy

ABSTRACT The human papillomavirus (HPV) type 16 (HPV16) E6 protein stimulates transcription of the catalytic subunit of telomerase, hTERT, in epithelial cells. It has been reported that binding to the ubiquitin ligase E6AP is required for this E6 activity, with E6 directing E6AP to the hTERT promoter. We previously reported two E6AP binding-defective HPV16 E6 mutations that induced immortalization of human mammary epithelial cells. Because activation of hTERT is proposed to be necessary for epithelial cell immortalization, we sought to further characterize the relationship between E6/E6AP association and telomerase induction. We demonstrate that while these E6 mutants do not bind E6AP, they retain the capability to stimulate the expression of hTERT. Chromatin immunoprecipitation assays confirmed the presence of Myc, wild-type E6, and the E6AP binding-defective E6 mutants, but not E6AP itself, at the endogenous hTERT promoter. Interestingly, an immortalization-defective E6 mutant localized to the hTERT promoter but failed to increase transcription. We conclude that binding to E6AP is not necessary for E6 localization to or activation of the hTERT promoter and that another activity of E6 is involved in hTERT activation.


Sign in / Sign up

Export Citation Format

Share Document